Editorial introductions
Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond
Systemic therapy after first-line docetaxel in metastatic castration-resistant prostate cancer
Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer
Management of dyspnea in advanced motor neuron diseases
Fatigue in chronically ill patients
Cognitive failure in end of life
Surgical approaches to metastatic spine disease
RANKL inhibition in the treatment of bone metastases
New drugs in multiple myeloma
Hematopoietic niche and bone meet
Cathepsin K inhibitors as treatment of bone metastasis
Current World Literature